Boothbay Fund Management’s Terns Pharmaceuticals TERN Stock Holding History

Boothbay Fund Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-350,000	Closed	-$18.5M	–	2628
2026 Q1	$18.5M	Buy	+350,000	New	+$14.4M	0.24%	46

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Boothbay Fund Management's TERN Position: Q2 2026 in Review

Boothbay Fund Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 486,170 shares — an estimated $25.6M sold.

Boothbay Fund Management first reported a position in TERN in Q2 2022 and held it in 16 quarters. The position peaked at $25.6M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Boothbay Fund Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Boothbay Fund Management sold 486,170 Terns Pharmaceuticals shares in Q2 2026, an estimated $25.6M.
Boothbay Fund Management first reported a position in Terns Pharmaceuticals in Q2 2022 and held it in 16 quarters.
Boothbay Fund Management's Terns Pharmaceuticals position peaked at $25.6M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.